期刊文献+

阿司匹林在防治缺血性脑卒中应注意的问题 被引量:4

下载PDF
导出
摘要 阿司匹林(aspirin)是防治缺血性脑卒中的常用药物,对血小板聚集有抑制作用,且不可逆。随着对阿司匹林药理作用及药效特点认识的提高,正确理解阿司匹林双向作用及阿司匹林抵抗,提倡小剂量、长期、个体化抗血小板治疗,提高患者依从性,已使更多的缺血性脑卒中患者从规范使用阿司匹林中获益。但是,在临床应用中还存在着一些问题,值得大家关注。
作者 朱金生
出处 《中国医药指南(学术版)》 2008年第10期82-83,共2页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献39

  • 1明淑萍,张晓琴.感染与缺血性脑卒中[J].卒中与神经疾病,2004,11(4):246-248. 被引量:6
  • 2张涓,万昕红,杨新春,丁枭伟,闫慧.心内科门诊患者使用阿司匹林情况的调查[J].中华全科医师杂志,2005,4(7):412-414. 被引量:11
  • 3Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
  • 4Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events.The SALT Collaborative Group.Lancet,1991,338:1345-1349.
  • 5European Stroke Prevention Study 2.Efficacy and safety data.J Neurol Sci,1997,151 Suppl:S1-S77.
  • 6Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.EAFT (European Atrial Fibrillation Trial) Study Group.Lancet,1993,342:1255-1262.
  • 7Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
  • 8The International Stroke Trial (IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19435 patients with acute ischaemic stroke.International Stroke Trial Collaborative Group.Lancet,1997,349:1569-1581.
  • 9CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.CAST (Chinese Acute Stroke Trial) Collaborative Group.Lancet,1997,349:1641-1649.
  • 10MeAlindon ME, Muller AF, Filipowiez B, et al. Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human wolunteers[ J ]. Gut, 1996, 38: 518-524.

共引文献121

同被引文献51

引证文献4

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部